S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
Log in

ASX:OSP - Osprey Medical Stock Price, Forecast & News

A$0.02
0.00 (0.00 %)
(As of 02/19/2020 04:00 PM ET)
Today's Range
A$0.02
Now: A$0.02
A$0.02
50-Day Range
A$0.02
MA: A$0.03
A$0.03
52-Week Range
A$0.02
Now: A$0.02
A$0.17
Volume900,831 shs
Average VolumeN/A
Market Capitalization$14.68 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Osprey Medical, Inc., a commercial stage company, focuses on protecting patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures in the United States and internationally. It offers AVERT, AVERT Plus, DyeVert Plus System, and DyeVert System, which reduces and monitors the contrast dye used in commonly performed heart, cardiovascular, and peripheral procedures. The company was founded in 2005 and is headquartered in Minnetonka, Minnesota.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone952-955-8230

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.15 million
Cash FlowA$0.04 per share
Book ValueA$0.04 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$14.68 million
Next Earnings DateN/A
OptionableNot Optionable

Receive OSP News and Ratings via Email

Sign-up to receive the latest news and ratings for OSP and its competitors with MarketBeat's FREE daily newsletter.


Osprey Medical (ASX:OSP) Frequently Asked Questions

What is Osprey Medical's stock symbol?

Osprey Medical trades on the ASX under the ticker symbol "OSP."

How were Osprey Medical's earnings last quarter?

Osprey Medical Inc (ASX:OSP) released its quarterly earnings data on Wednesday, August, 14th. The company reported ($0.04) EPS for the quarter. View Osprey Medical's Earnings History.

Has Osprey Medical been receiving favorable news coverage?

News articles about OSP stock have been trending somewhat positive recently, according to InfoTrie. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Osprey Medical earned a coverage optimism score of 0.7 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Osprey Medical.

Who are some of Osprey Medical's key competitors?

What other stocks do shareholders of Osprey Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Osprey Medical investors own include Macquarie Group (MQG), Magellan Financial Group (MFG), Medlab Clinical (MDC), FBR (FBR), Evolve Education Group (EVO), Dacian Gold (DCN), CCP Technologies (CT1), Bingo Industries (BIN), Afterpay Touch Group (APT) and Alkane Resources (ALK).

Who are Osprey Medical's key executives?

Osprey Medical's management team includes the folowing people:
  • Mr. Michael McCormick, Pres, CEO & Exec. Director (Age 57)
  • Dr. J. Edward Shapland, Co-Founder
  • Ms. Nancy Ness, VP of Fin. & CFO
  • Mr. Vic Fabano, VP of Operations & IT (Age 57)
  • Ms. Melanie Hess, VP of Regulatory Affairs, Compliance & Quality

What is Osprey Medical's stock price today?

One share of OSP stock can currently be purchased for approximately A$0.02.

How big of a company is Osprey Medical?

Osprey Medical has a market capitalization of $14.68 million and generates $3.15 million in revenue each year. View Additional Information About Osprey Medical.

What is Osprey Medical's official website?

The official website for Osprey Medical is http://www.ospreymed.com/.

How can I contact Osprey Medical?

The company can be reached via phone at 952-955-8230.


MarketBeat Community Rating for Osprey Medical (ASX OSP)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  13 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  30
MarketBeat's community ratings are surveys of what our community members think about Osprey Medical and other stocks. Vote "Outperform" if you believe OSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel